These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6134578)

  • 21. The distribution of immunoreactive chromogranins, S-100 protein, and vasoactive intestinal peptide in compound tumors of the adrenal medulla.
    Tischler AS; Dayal Y; Balogh K; Cohen RB; Connolly JL; Tallberg K
    Hum Pathol; 1987 Sep; 18(9):909-17. PubMed ID: 3623551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pheochromocytoma producing multiple vasoactive peptides.
    Herrera MF; Stone E; Deitel M; Asa SL
    Arch Surg; 1992 Jan; 127(1):105-8. PubMed ID: 1734841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoreactive vasoactive intestinal polypeptide in acinic cell carcinoma of the parotid gland.
    Hayashi Y; Nishida T; Yoshida H; Yanagawa T; Yura Y; Sato M
    Cancer; 1987 Sep; 60(5):962-8. PubMed ID: 3300954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of neuropeptide Y from pheochromocytomas.
    Takahashi K; Mouri T; Sone M; Murakami O; Itoi K; Ohneda M; Yoshinaga K
    Endocrinol Jpn; 1990 Feb; 37(1):53-60. PubMed ID: 2384052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal pheochromocytoma producing vasoactive intestinal peptide and masking hypertension.
    Ozbay A; Obukhau A; Buhl L; Brøndt Hartlev L; Løgstrup Poulsen P
    Horm Res; 2008; 70(3):188-92. PubMed ID: 18663320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organizational principles in the peripheral sympathetic nervous system: subdivision by coexisting peptides (somatostatin-, avian pancreatic polypeptide-, and vasoactive intestinal polypeptide-like immunoreactive materials).
    Lundberg JM; Hökfelt T; Anggård A; Terenius L; Elde R; Markey K; Goldstein M; Kimmel J
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1303-7. PubMed ID: 6122210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A patient with neurofibromatosis type 1 and watery diarrhoea syndrome due to a VIP-producing adrenal phaeochromocytoma.
    Quarles Van Ufford-Mannesse P; Castro Cabezas M; Vroom TM; Van Gils A; Lips CJ; Niermeijer P
    J Intern Med; 1999 Aug; 246(2):231-4. PubMed ID: 10447793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma.
    Lundberg JM; Hamberger B; Schultzberg M; Hökfelt T; Granberg PO; Efendić S; Terenius L; Goldstein M; Luft R
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4079-83. PubMed ID: 386355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Watery diarrhea, hypokalemia, achlorhydria syndrome due to recurrent malignant pheochromocytoma].
    Nigawara K; Suzuki T; Onodera T; Fukui K; Togashi S; Funyu T; Yamaya K; Terayama Y; Yamaguchi K
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):923-33. PubMed ID: 3322882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas.
    Schmid KW; Dockhorn-Dworniczak B; Fahrenkamp A; Kirchmair R; Tötsch M; Fischer-Colbrie R; Böcker W; Winkler H
    Histopathology; 1993 Jun; 22(6):527-33. PubMed ID: 8354485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspiration cytology and immunohistochemistry of a pheochromocytoma-ganglioneuroma of the adrenal gland.
    Layfield LJ; Glasgow BJ; Du Puis MH; Bhuta S
    Acta Cytol; 1987; 31(1):33-9. PubMed ID: 3468715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of immunoreactive-polypeptide hormones in cervical carcinoma.
    Inoue T; Yamaguchi K; Suzuki H; Abe K; Chihara T
    Cancer; 1984 Apr; 53(7):1509-14. PubMed ID: 6199101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal pheochromocytoma-ganglioneuroma producing catecholamines and various neuropeptides.
    Salmi J; Pelto-Huikko M; Auvinen O; Karvonen AL; Saaristo J; Paronen I; Pöyhönen L; Seppänen S
    Acta Med Scand; 1988; 224(4):403-8. PubMed ID: 3188992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunoassay study of hepatic clearance and disappearance half-time of somatostatin and vasoactive intestinal peptide in dogs.
    Chayvialle JA; Rayford PL; Thompson JC
    Gut; 1981 Sep; 22(9):732-7. PubMed ID: 6117506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoreactive corticotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma.
    Sasaki A; Yumita S; Kimura S; Miura Y; Yoshinaga K
    J Clin Endocrinol Metab; 1990 Apr; 70(4):996-9. PubMed ID: 1969422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance P, vasoactive intestinal polypeptide (VIP) and somatostatin levels in ocular tissue of normal and sensorily denervated rabbit eyes.
    Unger WG; Butler JM; Cole DF; Bloom SR; McGregor GP
    Exp Eye Res; 1981 Jun; 32(6):797-801. PubMed ID: 6166492
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors.
    Saito H; Saito S
    Horm Metab Res; 1982 Feb; 14(2):71-6. PubMed ID: 6121747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M; Suzuki M; Kato M
    Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.